Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
70
Recruiting, any sponsor type, condition "neuropathic pain"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed543
70 trials
Showing 1 to 25, recently updated first.
Nanchong Central HospitalGovernment (non-federal)
NCT07740707 · 88 participants (planned) · Start Aug 1, 2026 · Primary completion Mar 1, 2027
Drug: Standardized Routine Diabetic Foot Therapy · For: Refractory Diabetic Foot Neuropathic Pain
Sites: Nanchong, China
- Proof of Concept Trial of Cannabis Derivatives in Neuropathic PainPivotal-lookingRecruiting
VA Office of Research and DevelopmentFederal agency
NCT05351801 · 320 participants (planned) · Start Jun 21, 2023 · Primary completion Sep 29, 2028
Drug: THC (Syndros); CBD (Epidolex) and 2 more · For: Neuropathic Pain; Peripheral Neuropathic Pain
Sites: San Diego, California; West Los Angeles, California; West Haven, Connecticut · 6 sites in all
- Comparison of Local Methylcobalamin and Subcutaneous Lidocaine in Subacute Herpetic NeuralgiaRecruiting
CMH Multan Institute of Medical SciencesGovernment (non-federal)
NCT07938242 · 60 participants (planned) · Start Sep 1, 2026 · Primary completion Mar 1, 2027
Drug: Methylcobalamin; Injection lidocaine · For: Subacute Herpetic Neuralgia
Sites: Multan, Pakistan
Consano BioIndustry
NCT07264270 · 24 participants (planned) · Start Dec 3, 2025 · Primary completion Jun 2027
Drug: C-1101 · For: Lumbosacral Radicular Pain; Sciatic Radiculopathy; Sciatic Leg Pain and 3 more
Sites: Fernandina Beach, Florida; Winston-Salem, North Carolina; Richmond, Virginia · 6 sites in all
- A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPivotal-lookingRecruiting
Eli Lilly and CompanyEli Lilly (LLY)
NCT05986292 · 10,000 participants (planned) · Start Jan 30, 2020 · Primary completion Apr 2027
Drug: LY3016859 ISA; LY3556050 ISA and 5 more · For: Osteoarthritis, Knee; Diabetic Neuropathic Pain; Chronic Low-back Pain
Sites: Birmingham, Alabama; Glendale, Arizona; Phoenix, Arizona · 64 sites in all
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic PainPivotal-lookingRecruiting
Eli Lilly and CompanyEli Lilly (LLY)
NCT07285018 · 150 participants (planned) · Start Feb 16, 2026 · Primary completion Jul 2027
Drug: LY4065967; Placebo · For: Diabetic Peripheral Neuropathic Pain
Sites: Birmingham, Alabama; Phoenix, Arizona; Palm Springs, California · 36 sites in all
- RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal NeuralgiaRecruiting
Kriya Therapeutics, Inc.Industry
NCT07596485 · 24 participants (planned) · Start Sep 10, 2026 · Primary completion Feb 2029
Drug: Varenicline tartrate · For: Trigeminal Neuralgia
Sites: Sherbrooke, Canada
Centre for Addiction and Mental HealthAcademic, hospital or other
NCT06518720 · 16 participants (planned) · Start Apr 1, 2025 · Primary completion Mar 2027
Drug: Psilocybin 25 mg · For: Treatment Resistant Depression; Chronic Pain
Sites: Toronto, Canada
VM Therapeutics LLCIndustry
NCT07072468 · 16 participants (planned) · Start Dec 12, 2025 · Primary completion Jun 30, 2027
Drug: VMD-3866 Gel; Placebo Gel · For: Chemotherapy-induced Peripheral Neuropathy; Chemotherapy-induced Neuropathic Pain; CIPN - Chemotherapy-Induced Peripheral Neuropathy and 14 more
Sites: London, United Kingdom
Cairo UniversityAcademic, hospital or other
NCT07572994 · 30 participants (planned) · Start Nov 1, 2026 · Primary completion Apr 1, 2027
Drug: Lidocaine 2 %; Lidocaine + Sodium Bicarbonate · For: Myofacial Pain; Myofacial Pain Syndrome; Myofacial Pain Syndromes and 2 more
Sites: Cairo, Egypt
- Comparison of Two Postoperative Care Strategies After Breast SurgeryPivotal-lookingRecruiting
Moumtzidou Maria AikateriniAcademic, hospital or other
NCT07880223 · 108 participants (planned) · Start Oct 19, 2026 · Primary completion Aug 2027
Drug: Paracetamol; Dexketoprofen and 2 more · For: Postoperative Pain; Pain Management; Breast Surgery and 1 more
Sites: Heraklion, Greece
The Foundation for Orthopaedics and Regenerative MedicineAcademic, hospital or other
NCT05152368 · 20 participants (planned) · Start Sep 9, 2022 · Primary completion Jan 2028
Drug: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes · For: Peripheral Neuropathy; Trigeminal Neuralgia
Sites: Naples, Florida; Athens, Greece
Ataturk UniversityAcademic, hospital or other
NCT07550348 · 60 participants (planned) · Start Dec 1, 2025 · Primary completion Dec 1, 2026
Drug: Bupivacaine-Lidocaine Combination; Bupivacaine · For: Lower Extremity; Nerve Block; Pain, Postoperative and 1 more
Sites: Erzurum, Turkey (Türkiye)
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral NeuropathyPivotal-lookingRecruiting
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT06628908 · 1,100 participants (planned) · Start Oct 1, 2024 · Primary completion May 31, 2027
Drug: Suzetrigine; Placebo (matched to SUZ) and 2 more · For: Diabetic Peripheral Neuropathic Pain
Sites: Anniston, Alabama; Birmingham, Alabama; Daphne, Alabama · 76 sites in all
- Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.Pivotal-lookingRecruiting
Nantes University HospitalAcademic, hospital or other
NCT06023706 · 188 participants (planned) · Start Nov 8, 2023 · Primary completion May 8, 2027
Drug: Capsaicin 179 Mg Cutaneous Patch; Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2) · For: Coccyx Disorder; Neuropathic Pain; Coccygodynia
Sites: Brest, France; La Roche-sur-Yon, France; Nantes, France · 6 sites in all
- YJ001 Spray for Diabetic Peripheral Neuropathic PainPivotal-lookingRecruiting
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.Industry
NCT07859111 · 400 participants (planned) · Start Aug 3, 2026 · Primary completion Aug 30, 2028
Drug: YJ001 spray simulant; YJ001 spray and 2 more · For: Diabetic Peripheral Neuropathic Pain (DPNP)
Sites: Beijing, China
Istanbul Training and Research HospitalGovernment (non-federal)
NCT07844772 · 100 participants (planned) · Start Jun 11, 2026 · Primary completion Dec 2026
Drug: IL-17 Inhibitor Therapy; Conventional Systemic Therapy · For: Chronic Plaque-type Psoriasis
Sites: Istanbul, Turkey (Türkiye)
- Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)Pivotal-lookingRecruiting
Bernardino Clavo, MD, PhDAcademic, hospital or other
NCT04299893 · 42 participants (planned) · Start Nov 30, 2020 · Primary completion Sep 30, 2027
Drug: Ozone; Oxygen · For: Chemotherapy-induced Peripheral Neuropathy; Pain, Neuropathic; Pain Syndrome
Sites: Las Palmas de Gran Canaria, Spain · 2 sites in all
- SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.Pivotal-lookingRecruiting
University of RochesterAcademic, hospital or other
NCT06614322 · 190 participants (planned) · Start Feb 2, 2026 · Primary completion Jun 1, 2028
Drug: Pregabalin; Duloxetine · For: Painful Peripheral Neuropathy; Diabetic Peripheral Neuropathic Pain (DPN); Chemotherapy Induced Peripheral Neuropathy (CIPN) and 1 more
Sites: Boston, Massachusetts; New York, New York; Rochester, New York · 7 sites in all
Hospital Universitari de BellvitgeAcademic, hospital or other
NCT06851910 · 20 participants (planned) · Start Apr 21, 2025 · Primary completion Dec 2027
Drug: Lacosamide · For: Trigeminal Neuralgia
Sites: L'Hospitalet de Llobregat, Spain
- The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes ZosterPivotal-lookingRecruiting
Beijing Tiantan HospitalAcademic, hospital or other
NCT07361796 · 832 participants (planned) · Start Dec 15, 2025 · Primary completion Sep 30, 2027
Drug: Venlafaxine combined conventional therapy; Conventional therapy · For: Herpes Zoster; Pain; Postherpetic Neuralgia
Sites: Beijing, China
Sara Refaat Azab MetryAcademic, hospital or other
NCT07794475 · 60 participants (planned) · Start Aug 1, 2026 · Primary completion Feb 2027
Drug: Trimetazidine Dihydrochloride Tablets · For: Diabetic Peripheral Neuropathic Pain (DPN)
Sites: Cairo, Egypt
- Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)Pivotal-lookingRecruiting
Igor Wilderman. MDAcademic, hospital or other
NCT07762170 · 500 participants (planned) · Start Jul 30, 2026 · Primary completion Dec 2029
Drug: triamcinolone acetonide (Kenalog); Celestone Soluspan 6Mg/Ml Suspension for Injection and 2 more · For: Back Pain Lower Back; Neck Pain; Radiculopathy Multiple Sites and 6 more
Sites: Thornhill, Canada
- A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic NeuralgiaPivotal-lookingRecruiting
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.Industry
NCT07758920 · 200 participants (planned) · Start Aug 2026 · Primary completion Jun 2027
Drug: HL-1186; HL-1186 placebo and 2 more · For: Postherpetic Neuralgia ( PHN )
Sites: Beijing, China
James J. Peters Veterans Affairs Medical CenterFederal agency
NCT07251491 · 30 participants (planned) · Start Aug 6, 2026 · Primary completion Mar 1, 2028
Drug: Psilocybin (Usona Institute) · For: Spinal Cord Injury; Depression - Major Depressive Disorder; Veteran
Sites: The Bronx, New York
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.